FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2145082119> ?p ?o ?g. }

• W2145082119 endingPage "928" @default.
• W2145082119 startingPage "919" @default.
• W2145082119 abstract "This paper discusses the efficacy and safety of alendronate and risedronate in the treatment of postmenopausal osteoporosis.The literature was searched with the PubMed from 1996 to the present, with respect to strictly conducted systematic reviews with homogeneity, meta-analyses with homogeneity, and randomized controlled trials (RCTs) with narrow Confidence Interval.According to the results of large randomized controlled trials (RCTs), bisphosphonates (alendronate, risedronate, and ibandronate), raloxifene, calcitonin, parathyroid hormone (PTH), and strontium ranelate effectively prevent vertebral fractures in postmenopausal women with osteoporosis. Because raloxifene has been shown to be effective in preventing the initial vertebral fracture in postmenopausal osteoporotic women without prevalent vertebral fractures, it is considered in the treatment of postmenopausal women with mild osteoporosis or osteopenia with some risk factors for fractures. RCTs have also demonstrated that alendronate, risedronate, PTH, and strontium are useful to prevent non-vertebral fractures and that alendronate and risedronate prevent hip fractures, thus alendronate or risedronate are primarily considered as the first-line drugs in the treatment of elderly women with osteoporosis having some risk factors for falls. While it has been suggested that PTH may be considered in patients with severe osteoporosis, the use of PTH in the treatment for osteoporosis is limited to 2 years or less, and it may be appropriate to use other anti-resorptive drugs after the completion of PTH treatment to maintain the skeletal effects gained during the treatment. RCTs have demonstrated that the incidence of gastrointestinal tract adverse events in postmenopausal osteoporotic women treated with bisphosphonates and placebo are similar, and also the long-term efficacy and safety of alendronate and risedronate.The evidence derived from the literature, based on strict evidence-based medicine guidelines, suggests that there is long-term efficacy and safety with alendronate and risedronate in the treatment of osteoporosis in postmenopausal women." @default.
• W2145082119 created "2016-06-24" @default.
• W2145082119 creator A5044520068 @default.
• W2145082119 creator A5070620598 @default.
• W2145082119 creator A5074419878 @default.
• W2145082119 date "2006-04-07" @default.
• W2145082119 modified "2023-09-23" @default.
• W2145082119 title "Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis" @default.
• W2145082119 cites W1526946388 @default.
• W2145082119 cites W1969564030 @default.
• W2145082119 cites W1972185253 @default.
• W2145082119 cites W1978732954 @default.
• W2145082119 cites W1982417593 @default.
• W2145082119 cites W1987169166 @default.
• W2145082119 cites W1988174614 @default.
• W2145082119 cites W1989637027 @default.
• W2145082119 cites W1990123370 @default.
• W2145082119 cites W1990173735 @default.
• W2145082119 cites W1994888871 @default.
• W2145082119 cites W1996879430 @default.
• W2145082119 cites W2004779714 @default.
• W2145082119 cites W2009902348 @default.
• W2145082119 cites W2017834478 @default.
• W2145082119 cites W2021154017 @default.
• W2145082119 cites W2022094899 @default.
• W2145082119 cites W2023471859 @default.
• W2145082119 cites W2023781848 @default.
• W2145082119 cites W2024143452 @default.
• W2145082119 cites W2032886398 @default.
• W2145082119 cites W2035282044 @default.
• W2145082119 cites W2062300147 @default.
• W2145082119 cites W2062781570 @default.
• W2145082119 cites W2074855927 @default.
• W2145082119 cites W2077918310 @default.
• W2145082119 cites W2079725375 @default.
• W2145082119 cites W2079904952 @default.
• W2145082119 cites W2091228027 @default.
• W2145082119 cites W2096804803 @default.
• W2145082119 cites W2099955896 @default.
• W2145082119 cites W2104949625 @default.
• W2145082119 cites W2107177566 @default.
• W2145082119 cites W2110828193 @default.
• W2145082119 cites W2113550509 @default.
• W2145082119 cites W2119062112 @default.
• W2145082119 cites W2127071635 @default.
• W2145082119 cites W2133658100 @default.
• W2145082119 cites W2139196426 @default.
• W2145082119 cites W2147874800 @default.
• W2145082119 cites W2153009489 @default.
• W2145082119 cites W2156015681 @default.
• W2145082119 cites W2161837912 @default.
• W2145082119 cites W2162150486 @default.
• W2145082119 cites W2169512870 @default.
• W2145082119 cites W2232407802 @default.
• W2145082119 cites W2335178464 @default.
• W2145082119 doi "https://doi.org/10.1185/030079906x100276" @default.
• W2145082119 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16709313" @default.
• W2145082119 hasPublicationYear "2006" @default.
• W2145082119 type Work @default.
• W2145082119 sameAs 2145082119 @default.
• W2145082119 citedByCount "44" @default.
• W2145082119 countsByYear W21450821192012 @default.
• W2145082119 countsByYear W21450821192013 @default.
• W2145082119 countsByYear W21450821192014 @default.
• W2145082119 countsByYear W21450821192015 @default.
• W2145082119 countsByYear W21450821192016 @default.
• W2145082119 countsByYear W21450821192017 @default.
• W2145082119 countsByYear W21450821192018 @default.
• W2145082119 countsByYear W21450821192019 @default.
• W2145082119 countsByYear W21450821192020 @default.
• W2145082119 countsByYear W21450821192021 @default.
• W2145082119 countsByYear W21450821192023 @default.
• W2145082119 crossrefType "journal-article" @default.
• W2145082119 hasAuthorship W2145082119A5044520068 @default.
• W2145082119 hasAuthorship W2145082119A5070620598 @default.
• W2145082119 hasAuthorship W2145082119A5074419878 @default.
• W2145082119 hasConcept C121608353 @default.
• W2145082119 hasConcept C126322002 @default.
• W2145082119 hasConcept C168563851 @default.
• W2145082119 hasConcept C197934379 @default.
• W2145082119 hasConcept C2776541429 @default.
• W2145082119 hasConcept C2776594446 @default.
• W2145082119 hasConcept C2776886416 @default.
• W2145082119 hasConcept C2777083390 @default.
• W2145082119 hasConcept C2777176818 @default.
• W2145082119 hasConcept C2779809032 @default.
• W2145082119 hasConcept C2779889926 @default.
• W2145082119 hasConcept C2781104859 @default.
• W2145082119 hasConcept C530470458 @default.
• W2145082119 hasConcept C71924100 @default.
• W2145082119 hasConceptScore W2145082119C121608353 @default.
• W2145082119 hasConceptScore W2145082119C126322002 @default.
• W2145082119 hasConceptScore W2145082119C168563851 @default.
• W2145082119 hasConceptScore W2145082119C197934379 @default.
• W2145082119 hasConceptScore W2145082119C2776541429 @default.
• W2145082119 hasConceptScore W2145082119C2776594446 @default.
• W2145082119 hasConceptScore W2145082119C2776886416 @default.
• W2145082119 hasConceptScore W2145082119C2777083390 @default.

• next